000 | 01462 a2200433 4500 | ||
---|---|---|---|
005 | 20250518052144.0 | ||
264 | 0 | _c20210621 | |
008 | 202106s 0 0 eng d | ||
022 | _a1874-4702 | ||
024 | 7 |
_a10.2174/1874467212666190920144115 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFu, Ailing | |
245 | 0 | 0 |
_aMitotherapy as a Novel Therapeutic Strategy for Mitochondrial Diseases. _h[electronic resource] |
260 |
_bCurrent molecular pharmacology _c2020 |
||
300 |
_a41-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 | _aCell-Derived Microparticles |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCoronary Vessels |
650 | 0 | 4 | _aEnergy Metabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aInjections, Intra-Arterial |
650 | 0 | 4 | _aMammals |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMitochondria _xphysiology |
650 | 0 | 4 |
_aMitochondrial Diseases _xtherapy |
650 | 0 | 4 |
_aMyocardial Ischemia _xtherapy |
650 | 0 | 4 | _aNanotubes |
650 | 0 | 4 |
_aNeoplasms _xtherapy |
650 | 0 | 4 | _aOxygen Consumption |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 | _aSpecies Specificity |
773 | 0 |
_tCurrent molecular pharmacology _gvol. 13 _gno. 1 _gp. 41-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1874467212666190920144115 _zAvailable from publisher's website |
999 |
_c29939618 _d29939618 |